Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Panacea Biotec
Company

Panacea Biotec

Tracked across 1 events · 11 articles · First seen Feb 27, 2026 · Last active Feb 27, 2026

Sentiment
80
Attention
4
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 80
Tech
Panacea Biotec's DengiAll Enters Phase III Trials
Panacea Biotec has entered the final Phase III trials for its single-dose dengue vaccine, DengiAll, which could be a significant medical breakthrough. If approved, this vaccine would be the first of its kind available in India and could lead to substantial revenue and market share for the company.
Feb 27, 2026 · 11 articles
Relationships (2)
Syed Khalid Ali chief scientific officer ↔ Panacea Biotec Syed Khalid Ali is the chief scientific officer of Panacea Biotec.
India===Drugs Controller General of India regulator ↔ Panacea Biotec The India===Drugs Controller General of India provides final approval for Panace
NEWSDESK
Track Panacea Biotec live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.